
The community is sharply divided between bulls anticipating a short squeeze fueled by the nano float and rising Ebola headlines, and bears accusing the stock of being a pump-and-dump, as VRAX crashed from its $13+ peak to the $3-4 range following a $3.3M warrant exercise at $6 and ongoing dilution concerns.